Voyager Acquisition Corp. (VACH)

NASDAQ: VACH · Real-Time Price · USD
10.39
0.00 (0.00%)
At close: Jul 24, 2025, 4:00 PM
10.39
0.00 (0.00%)
After-hours: Jul 24, 2025, 4:15 PM EDT
Market Cap328.58M
Revenue (ttm)n/a
Net Income (ttm)6.63M
Shares Out 31.63M
EPS (ttm)0.30
PE Ratio35.15
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,641
Open10.38
Previous Close10.39
Day's Range10.38 - 10.39
52-Week Range9.95 - 11.20
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About VACH

Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. The company was incorporated in 2023 and is based in Brooklyn, New York. [Read more]

Sector Financials
IPO Date Aug 9, 2024
Country United States
Stock Exchange NASDAQ
Ticker Symbol VACH
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp.,  a Cayman Islands exempt...

7 days ago - GlobeNewsWire

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO with...

2 months ago - GlobeNewsWire

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel...

2 months ago - GlobeNewsWire

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Voyager Acquisition Corp. (Nasdaq: VACHU) announced today the pricing of its initial public offering of 22,000,000 units at $10.00 per unit.

1 year ago - GLOBE NEWSWIRE

Healthcare SPAC Voyager Acquisition files for a $261 million IPO

Voyager Acquisition, a blank check company targeting the healthcare sector, filed on Tuesday with the SEC to raise up to $261 million in an initial public offering.

1 year ago - Renaissance Capital

Voyager Acquisition IPO Registration Document (S-1)

Voyager Acquisition has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC